Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
BKD Stock Summary
Top 10 Correlated ETFs
BKD
In the News

Brookdale's (BKD) August 2023 Occupancy & Move-in Volumes Rise
Brookdale (BKD) has witnessed 22 straight months of year-over-year increases in the weighted average occupancy level.

Why Shares of Brookdale Senior Living Climbed This Week
Brookdale is the No. 1 provider of senior housing in the U.S. The company reported second-quarter earnings on Monday.

Brookdale Announces Date of Second Quarter 2023 Earnings Release and Conference Call
NASHVILLE, Tenn. , July 24, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) plans to release its second quarter 2023 financial results after the market closes on Monday, August 7, 2023.

Here's Why Buying Brookdale (BKD) Stock is a Prudent Move Now
For the second quarter, Brookdale (BKD) expects RevPAR growth to be in the range of 11.5-12%.

Brookdale (BKD) May 2023 Occupancy Rises: Better Days Ahead?
Brookdale (BKD) has witnessed 19 straight months of year-over-year increases in weighted average occupancy level.

Brookdale (BKD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Brookdale (BKD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Down -20.05% in 4 Weeks, Here's Why Brookdale (BKD) Looks Ripe for a Turnaround
Brookdale (BKD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher?
The week that ended April 14 was a good one for markets overall and a great one for two stocks in the healthcare sector. Sana Biotechnology jumped 58% higher last week as investors cheered preclinical results for its lead candidates.

Fast-paced Momentum Stock Brookdale (BKD) Is Still Trading at a Bargain
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
BKD Financial details
BKD Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 24.17 | 21.82 | 18.66 | 14.84 | 14.41 | |
Net income per share | -2.82 | -1.44 | 0.45 | -0.54 | -1.25 | |
Operating cash flow per share | 1.09 | 1.16 | 1.12 | -0.51 | 0.02 | |
Free cash flow per share | -0.11 | -0.47 | 0.11 | -1.47 | -1.02 | |
Cash per share | 2.2 | 1.66 | 3.02 | 2.86 | 2.35 | |
Book value per share | 5.44 | 3.75 | 4.36 | 3.77 | 3.06 | |
Tangible book value per share | 4.34 | 2.74 | 3.35 | 3.63 | -20.89 | |
Share holders equity per share | 5.44 | 3.75 | 4.36 | 3.77 | 3.06 | |
Interest debt per share | 25.58 | 32.86 | 30.78 | 29.27 | 26.77 | |
Market cap | 1.26B | 1.35B | 812.9M | 954.47M | 519.96M | |
Enterprise value | 5.05B | 6.38B | 5.64B | 5.83B | 5.01B | |
P/E ratio | -2.38 | -5.03 | 9.91 | -9.61 | -2.18 | |
Price to sales ratio | 0.28 | 0.33 | 0.24 | 0.35 | 0.19 | |
POCF ratio | 6.16 | 6.25 | 3.95 | -10.09 | 158.48 | |
PFCF ratio | -58.39 | -15.41 | 41.1 | -3.52 | -2.69 | |
P/B Ratio | 1.23 | 1.94 | 1.02 | 1.37 | 0.89 | |
PTB ratio | 1.23 | 1.94 | 1.02 | 1.37 | 0.89 | |
EV to sales | 1.12 | 1.57 | 1.65 | 2.12 | 1.83 | |
Enterprise value over EBITDA | 9.41 | 15.49 | 15.05 | 36.61 | 18.65 | |
EV to operating cash flow | 24.78 | 29.46 | 27.44 | -61.64 | 1.53K | |
EV to free cash flow | -234.98 | -72.71 | 285.31 | -21.5 | -25.89 | |
Earnings yield | -0.42 | -0.2 | 0.1 | -0.1 | -0.46 | |
Free cash flow yield | -0.02 | -0.06 | 0.02 | -0.28 | -0.37 | |
Debt to equity | 4.43 | 8.42 | 6.8 | 7.49 | 8.4 | |
Debt to assets | 0.7 | 0.81 | 0.79 | 0.82 | 0.82 | |
Net debt to EBITDA | 7.07 | 12.2 | 12.88 | 30.62 | 16.72 | |
Current ratio | 1 | 0.57 | 1.12 | 1.11 | 0.99 | |
Interest coverage | -2.12 | 0.11 | 0.05 | -0.99 | -0.41 | |
Income quality | -0.39 | -0.81 | 2.51 | 0.95 | -0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.12 | 0.12 | 0.13 | 0.13 | 0.12 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0 | 0 | |
Capex to operating cash flow | -1.11 | -1.41 | -0.9 | 1.87 | -60.02 | |
Capex to revenue | -0.05 | -0.07 | -0.05 | -0.06 | -0.07 | |
Capex to depreciation | -0.5 | -0.79 | -0.51 | -0.51 | -0.56 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 18.56 | 11.03 | 6.62 | 6.75 | 9.28 | |
ROIC | -0.09 | 0 | 0 | -0.02 | -0.01 | |
Return on tangible assets | -0.08 | -0.04 | 0.01 | -0.02 | -0.04 | |
Graham Net | -26 | -32.55 | -29.66 | -27.72 | -25.46 | |
Working capital | 685K | -450.8M | 82.87M | 67.04M | -4.11M | |
Tangible asset value | 812.81M | 509.4M | 614.54M | 672.3M | 556.83M | |
Net current asset value | -4.67B | -5.9B | -5.33B | -5.01B | -4.72B | |
Invested capital | 4.43 | 8.42 | 6.8 | 7.49 | 8.4 | |
Average receivables | 131.43M | 133.76M | 121.42M | 80.18M | 53.45M | |
Average payables | 93.44M | 99.89M | 87.98M | 73.68M | 73.56M | |
Average inventory | 132.21M | 95.16M | 56.82M | 37.3M | 29.11M | |
Days sales outstanding | 10.79 | 12.02 | 11.64 | 6.8 | 7.41 | |
Days payables outstanding | 10.02 | 12.02 | 9.48 | 12.31 | 11.62 | |
Days of inventory on hand | 12.73 | 7.98 | 5.87 | 4.93 | 4.54 | |
Receivables turnover | 33.84 | 30.36 | 31.35 | 53.7 | 49.23 | |
Payables turnover | 36.44 | 30.37 | 38.51 | 29.65 | 31.42 | |
Inventory turnover | 28.67 | 45.75 | 62.17 | 74.04 | 80.44 | |
ROE | -0.52 | -0.39 | 0.1 | -0.14 | -0.41 | |
Capex per share | -1.2 | -1.64 | -1.01 | -0.96 | -1.03 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 3.65 | 3.7 | 3.44 | 3.34 | 3.31 | |
Net income per share | -0.45 | -0.15 | -0.13 | -0.2 | -0.02 | |
Operating cash flow per share | 0.06 | 0.34 | -0.24 | 0.11 | 0.28 | |
Free cash flow per share | -0.24 | 0.05 | -0.47 | -0.11 | 0.02 | |
Cash per share | 2.16 | 2.08 | 2.21 | 1.92 | 1.92 | |
Book value per share | 2.76 | 2.63 | 2.88 | 2.4 | 2.39 | |
Tangible book value per share | -23.28 | 2.49 | -19.67 | 2.29 | 2.27 | |
Share holders equity per share | 2.76 | 2.63 | 2.88 | 2.4 | 2.39 | |
Interest debt per share | 27.87 | 27.62 | 24.49 | 21.88 | 21.94 | |
Market cap | 847.89M | 797.59M | 552.13M | 662.51M | 951.2M | |
Enterprise value | 5.77B | 5.6B | 5.05B | 5.16B | 5.5B | |
P/E ratio | -2.52 | -7.03 | -5.38 | -3.72 | -52.73 | |
Price to sales ratio | 1.24 | 1.15 | 0.79 | 0.88 | 1.27 | |
POCF ratio | 73.24 | 12.56 | -11.37 | 27.56 | 14.9 | |
PFCF ratio | -18.71 | 81.39 | -5.82 | -25.82 | 257.15 | |
P/B Ratio | 1.64 | 1.62 | 0.95 | 1.23 | 1.77 | |
PTB ratio | 1.64 | 1.62 | 0.95 | 1.23 | 1.77 | |
EV to sales | 8.47 | 8.11 | 7.25 | 6.87 | 7.37 | |
Enterprise value over EBITDA | 111.16 | 49.21 | 77.48 | 51.23 | 56.15 | |
EV to operating cash flow | 498.18 | 88.22 | -103.91 | 214.49 | 86.21 | |
EV to free cash flow | -127.26 | 571.81 | -53.16 | -200.98 | 1.49K | |
Earnings yield | -0.1 | -0.04 | -0.05 | -0.07 | 0 | |
Free cash flow yield | -0.05 | 0.01 | -0.17 | -0.04 | 0 | |
Debt to equity | 9.99 | 10.39 | 8.4 | 9 | 9.09 | |
Debt to assets | 0.84 | 0.84 | 0.82 | 0.83 | 0.83 | |
Net debt to EBITDA | 94.82 | 42.21 | 69 | 44.65 | 46.44 | |
Current ratio | 0.69 | 0.88 | 0.99 | 0.94 | 0.95 | |
Interest coverage | -0.73 | 0.36 | -0.42 | 0.24 | 0.71 | |
Income quality | -0.14 | -2.24 | 1.89 | -0.54 | -14.1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.12 | 0.12 | 0.12 | 0.13 | 0.13 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -4.91 | -0.85 | 0.95 | -2.07 | -0.94 | |
Capex to revenue | -0.08 | -0.08 | -0.07 | -0.07 | -0.08 | |
Capex to depreciation | -0.65 | -0.61 | -0.51 | -0.57 | -0.7 | |
Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
Graham number | 5.3 | 3 | 2.87 | 3.27 | 1.04 | |
ROIC | -0.01 | 0 | 0 | 0 | 0.01 | |
Return on tangible assets | -0.01 | 0 | 0 | -0.01 | 0 | |
Graham Net | -27.89 | -27.7 | -23.98 | -21.59 | -21.65 | |
Working capital | -266.55M | -75.57M | -4.11M | -40.85M | -32.06M | |
Tangible asset value | 491.25M | 465.48M | 556.83M | 513.53M | 511.96M | |
Net current asset value | -5.06B | -5.02B | -4.72B | -4.68B | -4.75B | |
Invested capital | 9.99 | 10.39 | 8.4 | 9 | 9.09 | |
Average receivables | 49.75M | 50.55M | 53.65M | 54.19M | 50.42M | |
Average payables | 79.33M | 77.18M | 74.35M | 79.87M | 91.63M | |
Average inventory | 0 | 0 | 13.87M | 40.33M | 43.88M | |
Days sales outstanding | 6.55 | 6.72 | 7.21 | 6.31 | 5.81 | |
Days payables outstanding | 12.52 | 12.42 | 11.27 | 14.11 | 15.06 | |
Days of inventory on hand | 0 | 0 | 4.4 | 8.42 | 5.55 | |
Receivables turnover | 13.75 | 13.4 | 12.48 | 14.27 | 15.48 | |
Payables turnover | 7.19 | 7.25 | 7.99 | 6.38 | 5.98 | |
Inventory turnover | 0 | 0 | 20.44 | 10.69 | 16.23 | |
ROE | -0.16 | -0.06 | -0.04 | -0.08 | -0.01 | |
Capex per share | -0.3 | -0.29 | -0.23 | -0.22 | -0.27 |
BKD Frequently Asked Questions
What is Brookdale Senior Living Inc. stock symbol ?
Brookdale Senior Living Inc. is a US stock , located in Brentwood of Tn and trading under the symbol BKD
Is Brookdale Senior Living Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $7. The lowest prediction is $7 and the highest is $7
What is BKD stock prediction ?
With a median analyst target price of $7, 1 stock analysts have made 1 forecasts in last 90 days. $7 is the lowest and $7 is the greatest projection.
What is Brookdale Senior Living Inc. stock quote today ?
Brookdale Senior Living Inc. stock price is $4.47 today.
Is Brookdale Senior Living Inc. stock public?
Yes, Brookdale Senior Living Inc. is a publicly traded company.